SCHEMBL5674124

SCHEMBL5674124

CCCC(C)(C)[Si](Cl)(C1CCCC1)C1CCCC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5675765 0.98 CYP1A2 (0.35) CYP1A2
SCHEMBL5699121 0.84 CYP1A2 (0.33) CYP1A2
SCHEMBL5699124 0.83 CYP1A2 (0.37) CYP1A2
SCHEMBL7568849 0.74
SCHEMBL4444246 0.74 CYP1A2 (0.33) CYP1A2
SCHEMBL4443938 0.72 CYP1A2 (0.36) CYP1A2
SCHEMBL7569267 0.72 CYP1A2 (0.32) CYP1A2
SCHEMBL1721423 0.68
SCHEMBL5674126 0.67
SCHEMBL136992 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518447-B2 Reacting 2,3-dimethyl-2-butene with a hydrogenchlorosilane compound in presence of aluminum chloride to form thexylchlorosilanes SHIN-ETSU CHEMICAL CO., LTD. (JP) 2003-02-11 US claimed
EP-1238980-B1 Silyl (meth)acrylates having bulky substituent group and preparation thereof SHINETSU CHEMICAL CO (JP) 2006-06-14 EP disclosed
EP-1203772-B1 Thexylchlorosilanes, their manufacture and use SHINETSU CHEMICAL CO (JP) 2006-01-11 EP disclosed
US-6518447-B2 Reacting 2,3-dimethyl-2-butene with a hydrogenchlorosilane compound in presence of aluminum chloride to form thexylchlorosilanes SHIN-ETSU CHEMICAL CO., LTD. (JP) 2003-02-11 US disclosed
US-6498264-B2 REACTING A CHLOROSILANE COMPOUND WITH ACRYLIC OR METHACRYLIC ACID IN THE PRESENCE OF A BASIC COMPOUND; PROTECTIVE HYDROLYSABLE COATINGS FOR SHIP BOTTOMS; NONTOXIC; POLLUTION CONTROL; KINETICS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-12-24 US disclosed
US-20020128503-A1 Silyl (meth)acrylates having bulky substituent group and preparation thereof SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-09-12 US disclosed
EP-1238980-A1 Silyl (meth)acrylates having bulky substituent group and preparation thereof SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-09-11 EP disclosed
US-20020055647-A1 Thexylchlorosilanes and making process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-05-09 US disclosed
EP-1203772-A2 Thexylchlorosilanes, their manufacture and use Shin-Etsu Chemical Co., Ltd. (JP) 2002-05-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128503-A1 Silyl (meth)acrylates having bulky substituent group and preparation thereof SMS, MASTL, ACR CYP1A2 1126/4885
US-20020055647-A1 Thexylchlorosilanes and making process LSS, SCLY, TET2 CYP1A2 953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.